biliary carcinoma

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Nov 15, 2023

Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • TQB3454 tablets matching placebo
  • Beijing, Beijing, China
  • +5 more
Aug 4, 2023

Biliary Carcinoma Trial in Nanjing (Disitamab Vedotin combined with Zimberelizumab)

Recruiting
  • Biliary Carcinoma
  • Disitamab Vedotin combined with Zimberelizumab
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Sep 14, 2022

Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

Recruiting
  • Pancreatic Adenocarcinoma
  • +3 more
  • Stockholm, Sweden
  • +1 more
Apr 4, 2022

Biliary Carcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Trial in Tampa (Cisplatin, Gemcitabine, Copanlisib)

Completed
  • Biliary Carcinoma
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 3, 2021

Biliary Carcinoma Trial in Nanning (Capecitabine, Apatinib)

Unknown status
  • Biliary Carcinoma
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 7, 2018

Biliary Carcinoma Trial in Italy (Panitumumab plus GEMOX chemo, GEMOX chemo)

Completed
  • Biliary Carcinoma
  • Panitumumab plus GEMOX chemotherapy
  • GEMOX chemotherapy
  • Aviano, Pordenone, Italy
  • +11 more
May 27, 2015